Ralogen is a drug used to prevent osteoporosis. It works by stimulating estrogen receptors in the bones, which helps prevent osteoporosis by enhancing bone strength, increasing bone density, reducing the possibility of bone damage, and preventing osteoporosis in postmenopausal women.
Ralogen is a selective estrogen receptor modulator, which works as an inhibitor of some estrogen receptor pathways while acting as a stimulator of other receptor pathways.